Immediate preoperative blood glucose and hemoglobin a1c levels are not predictive of postoperative infections in diabetic men undergoing penile prosthesis placement.


Journal

International journal of impotence research
ISSN: 1476-5489
Titre abrégé: Int J Impot Res
Pays: England
ID NLM: 9007383

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 14 02 2020
accepted: 11 03 2020
revised: 05 03 2020
pubmed: 24 3 2020
medline: 22 4 2021
entrez: 24 3 2020
Statut: ppublish

Résumé

Defining the risks associated with diabetes mellitus in patients undergoing penile prosthesis implantation remains controversial. Our study aims to assess whether preoperative hemoglobin a1c and preoperative blood glucose levels are associated with an increased risk for postoperative infection in diabetic men. We performed a retrospective review of 932 diabetic patients undergoing primary penile prosthesis implantation from 18 high-volume penile prosthesis implantation surgeons throughout the United States, Germany, Belgium, and South Korea. Preoperative hemoglobin a1c and blood glucose levels within 6 h of surgery were collected and assessed in univariate and multivariate models for correlation with postoperative infection, revision, and explantation rates. The primary outcome is postoperative infection and the secondary outcomes are postoperative revision and explantation. In all, 875 patients were included in the final analysis. There were no associations between preoperative blood glucose levels or hemoglobin a1c levels and postoperative infection rates; p = 0.220 and p = 0.598, respectively. On multivariate analysis, a history of diabetes-related complications was a significant predictor of higher revision rates (p = 0.034), but was nonsignificant for infection or explantation rates. We conclude preoperative blood glucose levels and hemoglobin a1c levels are not associated with an increased risk for postoperative infection, revision, or explantation in diabetic men undergoing penile prosthesis implantation.

Identifiants

pubmed: 32203432
doi: 10.1038/s41443-020-0261-5
pii: 10.1038/s41443-020-0261-5
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

296-302

Références

Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200:633–41. https://doi.org/10.1016/j.juro.2018.05.004 .
doi: 10.1016/j.juro.2018.05.004. pubmed: 29746858
Levine LA, Becher EF, Bella AJ, Brant WO, Kohler TS, Martinez-Salamanca JI, et al. Penile prosthesis surgery: current recommendations from the international consultation on sexual medicine. J Sex Med. 2016;13:489–518. https://doi.org/10.1016/j.jsxm.2016.01.017 .
doi: 10.1016/j.jsxm.2016.01.017. pubmed: 27045255
Huynh LM, Osman MM, Yafi FA. Risk profiling in patients undergoing penile prosthesis implantation. Asian J Androl. 2019. https://doi.org/10.4103/aja.aja_92_19 .
Narang GL, Figler BD, Coward RM. Preoperative counseling and expectation management for inflatable penile prosthesis implantation. Transl Androl Urol. 2017;6:S869–80. https://doi.org/10.21037/tau.2017.07.04 .
doi: 10.21037/tau.2017.07.04. pubmed: 29238666 pmcid: 5715186
Lipsky MJ, Onyeji I, Golan R, Munarriz R, Kashanian JA, Stember DS, et al. Diabetes is a risk factor for inflatable penile prosthesis infection: analysis of a large statewide database. Sex Med. 2019;7:35–40. https://doi.org/10.1016/j.esxm.2018.11.007 .
doi: 10.1016/j.esxm.2018.11.007. pubmed: 30674445 pmcid: 6377380
Bishop JR, Moul JW, Sihelnik SA, Peppas DS, Gormley TS, McLeod DG. Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections. J Urol. 1992;147:386–8. https://doi.org/10.1016/s0022-5347(17)37244-0 .
doi: 10.1016/s0022-5347(17)37244-0. pubmed: 1732600
Habous M, Tal R, Tealab A, Soliman T, Nassar M, Mekawi Z, et al. Defining a glycated haemoglobin (HbA1c) level that predicts increased risk of penile implant infection. BJU Int. 2018;121:293–300. https://doi.org/10.1111/bju.14076 .
doi: 10.1111/bju.14076. pubmed: 29124870
Wilson SK, Carson CC, Cleves MA, Delk JR 2nd. Quantifying risk of penile prosthesis infection with elevated glycosylated hemoglobin. J Urol. 1998;159:1537–9. https://doi.org/10.1097/00005392-199805000-00034 .
doi: 10.1097/00005392-199805000-00034. pubmed: 9554349
Canguven O, Talib R, El Ansari W, Khalafalla K, Al Ansari A. Is Hba1c level of diabetic patients associated with penile prosthesis implantation infections? Aging Male. 2018;9:1–6. https://doi.org/10.1080/13685538.2018.1448059 .
doi: 10.1080/13685538.2018.1448059.
Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pr. 2017;128:40–50. https://doi.org/10.1016/j.diabres.2017.03.024 .
doi: 10.1016/j.diabres.2017.03.024.
Okonkwo UA, DiPietro LA. Diabetes and wound angiogenesis. Int J Mol Sci. 2017;18:E1419. https://doi.org/10.3390/ijms18071419 .
doi: 10.3390/ijms18071419. pubmed: 28671607
Wang R, Panizales MT, Hudson MS, Rogers SO, Schnipper JL. Preoperative glucose as a screening tool in patients without diabetes. J Surg Res. 2014;186:371–8. https://doi.org/10.1016/j.jss.2013.09.014 .
doi: 10.1016/j.jss.2013.09.014. pubmed: 24148355
Davis MC, Ziewacz JE, Sullivan SE, El-Sayed AM. Preoperative hyperglycemia and complication risk following neurosurgical intervention: a study of 918 consecutive cases. Surg Neurol Int. 2012;3:49. https://doi.org/10.4103/2152-7806.96071 .
doi: 10.4103/2152-7806.96071. pubmed: 22629486 pmcid: 3356982
Shalaurova I, Connelly MA, Garvey WT, Otvos JD. Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance. Metab Syndr Relat Disord. 2014;12:422–9. https://doi.org/10.1089/met.2014.0050 .
doi: 10.1089/met.2014.0050. pubmed: 24959989 pmcid: 4175429
Harada PHN, Demler OV, Dugani SB, Akinkuolie AO, Moorthy MV, Ridker PM, et al. Lipoprotein insulin resistance score and risk of incident diabetes during extended follow-up of 20 years: the Women’s Health Study. J Clin Lipido. 2017;11:1257–67.e2. https://doi.org/10.1016/j.jacl.2017.06.008 .
doi: 10.1016/j.jacl.2017.06.008.

Auteurs

Mohamad M Osman (MM)

Department of Urology, Irvine Medical Center, University of California, Orange, CA, USA.

Linda M Huynh (LM)

Department of Urology, Irvine Medical Center, University of California, Orange, CA, USA.

Farouk M El-Khatib (FM)

Department of Urology, Irvine Medical Center, University of California, Orange, CA, USA.

Maxwell Towe (M)

Department of Urology, Irvine Medical Center, University of California, Orange, CA, USA.

Huang-Wei Su (HW)

Department of Urology, Irvine Medical Center, University of California, Orange, CA, USA.

Robert Andrianne (R)

Service d'urologie, Centre Hospitalier Universitaire de Liège, Liège, Belgium.

Gregory Barton (G)

Division of Urology, Duke University Medical Center, Durham, NC, USA.

Gregory Broderick (G)

Department of Urology, Mayo Clinic, Jacksonville, FL, USA.

Arthur L Burnett (AL)

The Johns Hopkins Hospital, Baltimore, MD, USA.

Jeffrey D Campbell (JD)

The Johns Hopkins Hospital, Baltimore, MD, USA.

Jonathan Clavell-Hernandez (J)

University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

Jessica Connor (J)

Department of Urology, Hackensack University Medical Center, Hackensack, NJ, USA.

Martin Gross (M)

Section of Urology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

Ross Guillum (R)

University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

Amy I Guise (AI)

Department of Urology, Medical College of Wisconsin, Milwaukee, WI, USA.

Georgios Hatzichristodoulou (G)

Department of Urology, Julius-Maximilians-University of Würzburg, Würzburg, Germany.

Gerard D Henry (GD)

ArkLaTex Urology, Bossier City, LA, USA.

Tung-Chin Hsieh (TC)

Department of Urology, UC San Diego Health System, San Diego, CA, USA.

Lawrence C Jenkins (LC)

Department of Urology, The Ohio State University, Columbus, OH, USA.

Christopher Koprowski (C)

Department of Urology, UC San Diego Health System, San Diego, CA, USA.

Kook B Lee (KB)

Sewum Prosthetic Urology Center of Excellence, Seoul, South Korea.

Aaron Lentz (A)

Division of Urology, Duke University Medical Center, Durham, NC, USA.

Ricardo M Munarriz (RM)

Department of Urology, Boston University Medical Center, Boston, MA, USA.

Daniar Osmonov (D)

Department of Urology, University Hospital Schleswig Holstein, Campus Kiel, Germany.

Shu Pan (S)

Department of Urology, Boston University Medical Center, Boston, MA, USA.

Kevin Parikh (K)

Department of Urology, Mayo Clinic, Jacksonville, FL, USA.

Sung Hun Park (SH)

Sewum Prosthetic Urology Center of Excellence, Seoul, South Korea.

Amir S Patel (AS)

Department of Urology, Fox Chase Cancer Center, Einstein Healthcare Network, Philadelphia, PA, USA.

Paul Perito (P)

Perito Urology, Coral Gables, FL, USA.

Hossein Sadeghi-Nejad (H)

Department of Urology, Hackensack University Medical Center, Hackensack, NJ, USA.

Maxime Sempels (M)

Service d'urologie, Centre Hospitalier Universitaire de Liège, Liège, Belgium.

Jay Simhan (J)

Department of Urology, Fox Chase Cancer Center, Einstein Healthcare Network, Philadelphia, PA, USA.

Run Wang (R)

University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

Faysal A Yafi (FA)

Department of Urology, Irvine Medical Center, University of California, Orange, CA, USA. fyafi@uci.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH